Federated Hermes’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.5M | Sell |
2,049,501
-5,699
| -0.3% | -$207K | 0.14% | 180 |
|
|
2025
Q1 | $74.4M | Buy |
2,055,200
+5,400
| +0.3% | +$196K | 0.16% | 164 |
|
|
2024
Q4 | $86.2M | Sell |
2,049,800
-60,900
| -3% | -$2.56M | 0.19% | 141 |
|
|
2024
Q3 | $117M | Buy |
2,110,700
+3,675
| +0.2% | +$204K | 0.26% | 91 |
|
|
2024
Q2 | $86.6M | Buy |
2,107,025
+168,345
| +9% | +$6.92M | 0.21% | 117 |
|
|
2024
Q1 | $90.5M | Sell |
1,938,680
-507,820
| -21% | -$23.7M | 0.21% | 124 |
|
|
2023
Q4 | $117M | Buy |
2,446,500
+250,000
| +11% | +$12M | 0.29% | 76 |
|
|
2023
Q3 | $78.3M | Buy |
2,196,500
+419,900
| +24% | +$15M | 0.21% | 118 |
|
|
2023
Q2 | $82M | Sell |
1,776,600
-749,000
| -30% | -$34.6M | 0.2% | 108 |
|
|
2023
Q1 | $101M | Sell |
2,525,600
-568,900
| -18% | -$22.8M | 0.25% | 85 |
|
|
2022
Q4 | $143M | Sell |
3,094,500
-721,897
| -19% | -$33.4M | 0.4% | 49 |
|
|
2022
Q3 | $158M | Buy |
3,816,397
+19,308
| +0.5% | +$800K | 0.46% | 41 |
|
|
2022
Q2 | $227M | Sell |
3,797,089
-190,639
| -5% | -$11.4M | 0.62% | 28 |
|
|
2022
Q1 | $290M | Buy |
3,987,728
+858
| +0% | +$62.3K | 0.65% | 21 |
|
|
2021
Q4 | $335M | Sell |
3,986,870
-162
| -0% | -$13.6K | 0.62% | 19 |
|
|
2021
Q3 | $360M | Buy |
3,987,032
+135,722
| +4% | +$12.2M | 0.68% | 18 |
|
|
2021
Q2 | $367M | Sell |
3,851,310
-61,098
| -2% | -$5.83M | 0.68% | 18 |
|
|
2021
Q1 | $445M | Sell |
3,912,408
-368,120
| -9% | -$41.9M | 0.86% | 11 |
|
|
2020
Q4 | $593M | Buy |
4,280,528
+186,213
| +5% | +$25.8M | 1.21% | 3 |
|
|
2020
Q3 | $337M | Buy |
4,094,315
+13,956
| +0.3% | +$1.15M | 0.79% | 17 |
|
|
2020
Q2 | $319M | Buy |
4,080,359
+63,599
| +2% | +$4.97M | 0.79% | 20 |
|
|
2020
Q1 | $178M | Buy |
4,016,760
+1,044,752
| +35% | +$46.4M | 0.52% | 33 |
|
|
2019
Q4 | $127M | Buy |
2,972,008
+117,698
| +4% | +$5.03M | 0.28% | 76 |
|
|
2019
Q3 | $122M | Buy |
2,854,310
+1,079,658
| +61% | +$46.2M | 0.3% | 68 |
|
|
2019
Q2 | $113M | Buy |
1,774,652
+25,378
| +1% | +$1.61M | 0.27% | 78 |
|
|
2019
Q1 | $121M | Buy |
1,749,274
+471,955
| +37% | +$32.7M | 0.3% | 68 |
|
|
2018
Q4 | $55.5M | Sell |
1,277,319
-206,952
| -14% | -$9M | 0.15% | 139 |
|
|
2018
Q3 | $113M | Buy |
1,484,271
+66,720
| +5% | +$5.09M | 0.26% | 79 |
|
|
2018
Q2 | $109M | Buy |
1,417,551
+218,060
| +18% | +$16.8M | 0.32% | 71 |
|
|
2018
Q1 | $61.2M | Buy |
1,199,491
+98,691
| +9% | +$5.03M | 0.18% | 110 |
|
|
2017
Q4 | $51.1M | Buy |
1,100,800
+709,200
| +181% | +$32.9M | 0.14% | 124 |
|
|
2017
Q3 | $20.9M | Sell |
391,600
-25,500
| -6% | -$1.36M | 0.06% | 253 |
|
|
2017
Q2 | $25.9M | Hold |
417,100
| – | – | 0.07% | 231 |
|
|
2017
Q1 | $28.3M | Sell |
417,100
-21,200
| -5% | -$1.44M | 0.08% | 214 |
|
|
2016
Q4 | $30.8M | Sell |
438,300
-4,300
| -1% | -$302K | 0.09% | 184 |
|
|
2016
Q3 | $31.4M | Sell |
442,600
-450
| -0.1% | -$31.9K | 0.09% | 177 |
|
|
2016
Q2 | $21.7M | Hold |
443,050
| – | – | 0.06% | 255 |
|
|
2016
Q1 | $28M | Buy |
443,050
+43,250
| +11% | +$2.74M | 0.09% | 200 |
|
|
2015
Q4 | $44.9M | Buy |
399,800
+650
| +0.2% | +$72.9K | 0.14% | 141 |
|
|
2015
Q3 | $38.4M | Buy |
399,150
+550
| +0.1% | +$53K | 0.12% | 167 |
|
|
2015
Q2 | $40.8M | Hold |
398,600
| – | – | 0.12% | 177 |
|
|
2015
Q1 | $24.7M | Buy |
398,600
+109,700
| +38% | +$6.81M | 0.08% | 251 |
|
|
2014
Q4 | $12.7M | Hold |
288,900
| – | – | 0.04% | 392 |
|
|
2014
Q3 | $16.4M | Buy |
288,900
+150,000
| +108% | +$8.49M | 0.05% | 327 |
|
|
2014
Q2 | $6.24M | Sell |
138,900
-2,400
| -2% | -$108K | 0.02% | 585 |
|
|
2014
Q1 | $6.91M | Buy |
+141,300
| New | +$6.91M | 0.02% | 562 |
|